Action of Reverse T3 on Cancer Cells

Endocr Res. 2019 Nov;44(4):148-152. doi: 10.1080/07435800.2019.1600536. Epub 2019 Apr 3.

Abstract

Background: Reverse T3 (rT3; 3,3',5'-triiodo-L-thyronine) is widely regarded as an inactive naturally occurring analog of thyroid hormone. rT3 is known to bind to the thyroid hormone analog receptor on plasma membrane integrin αvβ3. This integrin is generously expressed by tumor cells and is the initiation site for the stimulation by L-thyroxine (T4) at physiological free concentrations on cancer cell proliferation. Results: In the present studies, we show that rT3 caused increases of proliferation in vitro of 50% to 80% (P < 0.05-0.001) of human breast cancer and glioblastoma cells. Conclusion: rT3 may be a host factor supporting cancer growth.

Keywords: 3,3',5’-triiodo-L-thyronine; Integrin αvβ3; L-thyroxine; breast cancer; glioblastoma.

MeSH terms

  • Adenocarcinoma / pathology
  • Brain Neoplasms / pathology
  • Breast Neoplasms / pathology
  • Cell Proliferation / drug effects*
  • Dose-Response Relationship, Drug
  • Female
  • Glioblastoma / pathology
  • Humans
  • MCF-7 Cells
  • Neoplasms / pathology*
  • Triiodothyronine, Reverse / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Triiodothyronine, Reverse